HS is a skin condition that causes small, painful lumps to form beneath the skin. The lumps usually appear in areas where skin rubs together such as the armpits, groin, and under the breasts. Despite its appearance, HS is not contagious.
Every day feels uncertain when you live with hidradenitis suppurativa (HS). Painful lumps can disrupt almost any activity, leaving you with relentless discomfort. We're currently evaluating a study medicine that is a pill you swallow daily to see if it can help get better control of HS symptoms. If you are interested in exploring options, we invite you to learn about our clinical trial.
Our clinical trial is looking for people who are living with HS to see if a study medicine that is a pill you swallow daily can help better control symptoms. If you choose to take part in this clinical trial, you’ll receive care from a team of dedicated specialists that could help us continue to make progress for HS research.
Who may participate
This clinical trial may be an option for adults who have moderate to severe hidradenitis suppurativa (HS) with lumps in at least 2 different areas of the body and who still have HS symptoms after taking at least 4 weeks of oral antibiotics.
There will be other requirements that the trial team will discuss with you.
Joining a clinical trial is an important and personal decision. We thank you for considering taking part as an option that may be right for you.
Condition
Hidradenitis suppurativa (HS)
Age
18 to 75 years old
Sex
Male or Female
Each clinical study has its own guidelines for who can participate, called eligibility criteria. However, only the research study staff can determine if you qualify to enroll in the study.
What to expect
Half of the participants will receive the study medicine, and half will receive the placebo. A placebo does not have any medicine in it but looks just like the medicine being studied. You may be able to continue taking your current HS medicine. The study team will give you more information.
Length of study treatment
Up to 4 months
Number of study visits
10 visits
Long-term follow-up
You’ll have a follow-up visit approximately 1 month after the treatment period
Benefits of the clinical trial
Benefits of the clinical trial
- This clinical trial offers an opportunity for individuals living with moderate to severe HS to explore a potential new treatment that may better control symptoms and reduce flare-ups
- Participants will receive expert care from a dedicated medical team
- All trial-related care, including study medicine, will be provided at no cost
- You will gain access to the latest research and may help advance the future of HS treatments
About hidradenitis suppurativa (HS)
About hidradenitis suppurativa (HS)
Frequently asked questions
Why is this research important?
The trial will evaluate a potential new treatment for moderate to severe HS, hoping to improve symptoms and reduce flare-ups.
Who can participate in the clinical trial?
Adults diagnosed with moderate to severe HS who are between 18 and 75 and still have HS symptoms after taking at least 4 weeks of oral antibiotics. A medical team will assess each potential participant to ensure the trial is a good fit.
Will I have to pay for anything during the trial?
All trial-related care, including study medication, will be provided at no cost.
Will I get the study medicine or a placebo?
If this trial is a good fit for you and you decide to take part, you will receive either a placebo or the study medicine. A placebo does not have any medicine in it but looks just like the medicine being studied.
Half of the participants will receive the study medicine, and half will receive the placebo. You may be able to continue taking your current HS medicine. The study team will give you more information.
What types of tests can I expect during the clinical trial?
Your study doctor will conduct a physical exam and a series of tests similar to those you may have at a regular doctor’s visit.
